By Chelsea Naso ( March 16, 2016, 2:09 PM EDT) -- Vectura Group plc will snap up fellow U.K.-based inhaler developer Skyepharma PLC in a £441.3 million ($622 million) stock transaction, paving the way for the combined biotech to gain access to the $35 billion global inhaled respiratory market, according to a London regulatory filing....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.